Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.39 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 6/20 | 0.38 |
| ▸ | CA9 | Q16790 | 6/20 | 0.38 |
| ▸ | APP | P05067 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL865841 | 0.95 | ABCG2 (0.39) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 | |
| SCHEMBL865842 | 0.95 | ABCG2 (0.39) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 | |
| SCHEMBL5019480 | 0.93 | ABCG2 (0.38) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 | |
| SCHEMBL679419 | 0.93 | ABCB1 (0.45) | ABCG2ABCB1ABCC1CA12CA9 | |
| SCHEMBL14520605 | 0.91 | ABCG2 (0.38) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 | |
| SCHEMBL18993092 | 0.91 | ABCG2 (0.38) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 | |
| SCHEMBL15315058 | 0.90 | CA12 (0.39) | ABCG2ABCB1ABCC1ESR1CA12 | |
| SCHEMBL15362275 | 0.89 | ESR1 (0.38) | CYP1A1CYP1B1ABCG2ESR1CA12 | |
| SCHEMBL865816 | 0.88 | CA12 (0.38) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 | |
| SCHEMBL864566 | 0.88 | CA12 (0.38) | CYP1A1CYP1B1ABCG2ABCB1ABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329823-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-12-11 | — | — | US | disclosed |
| US-8329823-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-12-11 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | CYP1A1 3056/4885CYP1B1 2893/4885MAOB 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.